| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Péter P Nánási | |
| Zoltán Szabó | |||
| Veronika Sebestyén | |||
| Dóra Ujvárosy | |||
| Tamás Ötvös | |||
| P2860 | cites work | Drug induced QT prolongation and torsades de pointes | Q24673854 |
| Mechanical chest compression for out of hospital cardiac arrest: Systematic review and meta-analysis | Q26799190 | ||
| The role of late I Na in development of cardiac arrhythmias | Q26823149 | ||
| Long-QT syndrome: from genetics to management | Q26823298 | ||
| How to perform and interpret provocative testing for the diagnosis of Brugada syndrome, long-QT syndrome, and catecholaminergic polymorphic ventricular tachycardia | Q27011445 | ||
| Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction | Q28072276 | ||
| Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction | Q28208692 | ||
| Antimicrobial safety: focus on fluoroquinolones | Q28255152 | ||
| Part 1: Executive Summary: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care | Q28268692 | ||
| Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction | Q28287618 | ||
| Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis | Q28308142 | ||
| Microvolt T-Wave Alternans Distinguishes Between Patients Likely and Patients Not Likely to Benefit From Implanted Cardiac Defibrillator Therapy: A Solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Conundrum | Q29308392 | ||
| Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest | Q29615549 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Prognostic Value of a New Marker of Ventricular Repolarization in Cirrhotic Patients | Q30100970 | ||
| Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association | Q30238784 | ||
| Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. | Q30382926 | ||
| Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure | Q43489268 | ||
| Immediate coronary angiogram in comatose survivors of out-of-hospital cardiac arrest--an Australian study | Q43583123 | ||
| Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin | Q43838827 | ||
| Termination of ventricular tachycardia with bursts of rapid ventricular pacing | Q43925941 | ||
| T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. | Q44057427 | ||
| Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators | Q44086151 | ||
| Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. | Q44465520 | ||
| Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment | Q44490303 | ||
| Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure | Q44604921 | ||
| Tricyclic antidepressants, QT interval prolongation, and torsade de pointes | Q44904667 | ||
| Incidence of EMS-treated out-of-hospital cardiac arrest in the United States | Q45021820 | ||
| Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials | Q45113230 | ||
| Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator | Q45144388 | ||
| Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial. | Q46132135 | ||
| Subclinical hypothyroidism is characterized by increased QT interval dispersion among women | Q46441864 | ||
| Effect of hyperlipidemia on QT dispersion in patients without ischemic heart disease. | Q46656683 | ||
| Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery | Q46856882 | ||
| Location and density of alpha- and beta-adrenoreceptor sub-types in myocardium after mechanical left ventricular unloading. | Q47611160 | ||
| European Resuscitation Council Guidelines for Resuscitation 2015: Section 3. Adult advanced life support. | Q47637603 | ||
| Potassium channel down-regulation in heart failure | Q48008717 | ||
| Drugs in cardiac arrest: the rise and fall of antiarrhythmics | Q48197159 | ||
| Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks | Q48233485 | ||
| Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio are prolonged in patients with moderate and severe obstructive sleep apnea | Q48239858 | ||
| Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators | Q48898746 | ||
| Part 5: Acute coronary syndromes: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations | Q48931354 | ||
| Evaluation of Tpe interval and Tpe/QT ratio in patients with slow coronary flow | Q49447896 | ||
| Sudden Cardiac Death in Ischemic Heart Disease: Pathophysiology and Risk Stratification. | Q49659636 | ||
| Clinical and Angiographic Predictors of Mortality in Sudden Cardiac Arrest Patients Having Cardiac Catheterisation: A Single Centre Registry | Q49833893 | ||
| Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally | Q41880829 | ||
| Perindopril for improving cardiovascular events | Q42864618 | ||
| Oxidative stress, fibrosis, and early afterdepolarization-mediated cardiac arrhythmias. | Q43246929 | ||
| Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator | Q43405859 | ||
| Cardiac amyloidosis presenting with prolonged QT interval and recurrent polymorphic ventricular tachycardia | Q30539669 | ||
| Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine | Q30622882 | ||
| Natural history of Brugada syndrome: insights for risk stratification and management | Q33147491 | ||
| Sudden cardiac arrest associated with early repolarization | Q33156255 | ||
| Gender differences in clinical manifestations of Brugada syndrome. | Q33156827 | ||
| Brugada syndrome 2012. | Q33161523 | ||
| Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study | Q33167640 | ||
| Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). | Q33248754 | ||
| An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing | Q33655317 | ||
| J wave syndromes. | Q33746545 | ||
| Prevention of sudden cardiac death with beta blockers. | Q33754170 | ||
| Increased short-term variability of the QT interval in professional soccer players: possible implications for arrhythmia prediction. | Q33883743 | ||
| Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals | Q33954488 | ||
| Measurement, interpretation and clinical potential of QT dispersion. | Q34090620 | ||
| Global incidences of out-of-hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies | Q34137046 | ||
| Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 | ||
| Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure | Q34386004 | ||
| Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. | Q34387461 | ||
| Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells | Q34510462 | ||
| Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest | Q34520752 | ||
| Amiodarone and cardiac arrest: Systematic review and meta-analysis. | Q34534581 | ||
| Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 | ||
| Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). | Q34682919 | ||
| Antipsychotic-related QTc prolongation, torsade de pointes and sudden death | Q34730759 | ||
| Use of ejection fraction (or lack thereof), morbidity/mortality and heart failure drug trials: a review | Q34749797 | ||
| Reference values of electrocardiogram repolarization variables in a healthy population. | Q35001833 | ||
| Antipsychotics and QT prolongation | Q35048069 | ||
| Electrocardiographic QT interval and mortality: a meta-analysis | Q35147781 | ||
| Use of nonantiarrhythmic drugs for prevention of sudden cardiac death | Q35209701 | ||
| Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk. | Q35210010 | ||
| Out-of-hospital cardiac arrest survival improving over time: Results from the Resuscitation Outcomes Consortium (ROC). | Q35612224 | ||
| Rational strategy to stop arrhythmias: Early afterdepolarizations and L-type Ca2+ current. | Q35642617 | ||
| Comparison of role of early (less than six hours) to later (more than six hours) or no cardiac catheterization after resuscitation from out-of-hospital cardiac arrest | Q35723357 | ||
| Sudden cardiac death risk stratification | Q35738748 | ||
| Role of gap junctions in the propagation of the cardiac action potential | Q35749980 | ||
| The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. | Q51082214 | ||
| Short QT syndrome and arrhythmogenic cardiac diseases in the young: the challenge of implantable cardioverter-defibrillator therapy for children. | Q51137099 | ||
| Quality between mechanical compression on reducible stretcher versus manual compression on standard stretcher in small elevator. | Q51286151 | ||
| Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. | Q51592904 | ||
| Comparative analysis of methods for automatic detection and quantification of microvolt T-wave alternans. | Q51792814 | ||
| Predicting survival from out-of-hospital cardiac arrest: a graphic model. | Q52388890 | ||
| Ablation Approaches for Ventricular Fibrillation. | Q52672766 | ||
| QT dispersion in patients with end-stage renal failure and during hemodialysis. | Q52912971 | ||
| Refractory ventricular fibrillation treated with esmolol. | Q53145371 | ||
| Effects of combination of sotalol and verapamil on initiation, maintenance, and termination of ventricular fibrillation in swine hearts. | Q53840923 | ||
| Factors associated with an increased chance of survival among patients suffering from an out-of-hospital cardiac arrest in a national perspective in Sweden. | Q54760682 | ||
| Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. | Q55067212 | ||
| The role of adrenaline in cardiopulmonary resuscitation. | Q55153876 | ||
| Safety of mechanical chest compression devices AutoPulse and LUCAS in cardiac arrest: a randomized clinical trial for non-inferiority. | Q55332422 | ||
| Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. | Q55638651 | ||
| 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death | Q55983200 | ||
| Sudden Death in Young Adults | Q56554682 | ||
| Reappraisal of Reported Genes for Sudden Arrhythmic Death: An Evidence-Based Evaluation of Gene Validity for Brugada Syndrome | Q56888447 | ||
| Mapping and Ablation of Idiopathic Ventricular Fibrillation | Q57073646 | ||
| The Properties of the Pacemaker Current IFin Human Ventricular Myocytes are Modulated by Cardiac Disease | Q59591148 | ||
| Cardiovascular risk factors differently affect the survival of patients undergoing manual or mechanical resuscitation | Q59790161 | ||
| Hemodiafiltration beneficially affects QT interval duration and dispersion compared to hemodialysis | Q61427439 | ||
| Door-to-Targeted Temperature Management Initiation Time and Outcomes in Out-of-Hospital Cardiac Arrest: Insights From the Continuous Chest Compressions Trial | Q64065569 | ||
| Drone delivery of an automated external defibrillator - a mixed method simulation study of bystander experience | Q64068414 | ||
| Predictors of cardiac arrhythmic events in non coronary artery disease patients | Q64069808 | ||
| Beyond Advanced Cardiac Life Support: Dual-sequential Defibrillation for Refractory Ventricular Fibrillation after Witnessed Cardiac Arrest in the Emergency Department. | Q64986410 | ||
| Changes over time in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction: perspectives from the Worcester Heart Attack Study. | Q64993746 | ||
| Sudden death | Q68133933 | ||
| Amiodarone | Q68930408 | ||
| Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study) | Q70112487 | ||
| Sudden death in a pediatric cardiology population, 1958 to 1983: relation to prior arrhythmias | Q70112539 | ||
| Antiarrhythmic agent amiodarone possesses calcium channel blocker properties | Q71675958 | ||
| Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis | Q72198058 | ||
| Primary coronary angioplasty for acute myocardial infarction complicated by out-of-hospital cardiac arrest | Q72230702 | ||
| Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol | Q72589382 | ||
| T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity | Q73662553 | ||
| ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 199 | Q73904936 | ||
| Clinical determinants of increased QT dispersion in patients with diabetes mellitus | Q74230139 | ||
| QT interval and QT dispersion in systemic sclerosis (scleroderma) | Q74497294 | ||
| Taking the "idio" out of "idiosyncratic": predicting torsades de pointes | Q74595554 | ||
| Predicting sudden death in the population: the Paris Prospective Study I | Q77342545 | ||
| Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study | Q80401265 | ||
| Genetics of Brugada syndrome | Q83180897 | ||
| Brugada syndrome caused by a large deletion in SCN5A only detected by multiplex ligation-dependent probe amplification | Q83353831 | ||
| Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium | Q83609756 | ||
| Relation of increased short-term variability of QT interval to congenital long-QT syndrome | Q83752904 | ||
| Short-term variability of repolarization predicts ventricular tachycardia and sudden cardiac death in patients with structural heart disease: a comparison with QT variability index | Q84432190 | ||
| Usefulness of short-term variability of QT intervals as a predictor for electrical remodeling and proarrhythmia in patients with nonischemic heart failure | Q84517532 | ||
| Multicenter automatic defibrillator implantation trial: reduce inappropriate therapy (MADIT-RIT): background, rationale, and clinical protocol | Q84592308 | ||
| A patient with recurrent atrial fibrillation and monomorphic ventricular tachycardia treated successfully with dronedarone | Q85238084 | ||
| Epigenetics and cardiovascular disease | Q85768193 | ||
| 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practi | Q89811077 | ||
| Mapping and Ablation of Ventricular Fibrillation Associated With Early Repolarization Syndrome | Q90203560 | ||
| 2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation | Q90667170 | ||
| Determination and Interpretation of the QT Interval | Q90669120 | ||
| Electrogram recording and analyzing techniques to optimize selection of target sites for ablation of cardiac arrhythmias | Q90686800 | ||
| Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial | Q90719052 | ||
| ST-segment elevation and the Tpeak-Tend/QT ratio predict the occurrence of malignant arrhythmia events in patients with vasospastic angina | Q90923618 | ||
| ATP-Sensitive Potassium Channels and Their Physiological and Pathophysiological Roles | Q91446271 | ||
| Three Generations of β-blockers: History, Class Differences and Clinical Applicability | Q91514410 | ||
| Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients | Q91541165 | ||
| Evaluation of out-of-hospital cardiac arrest using transesophageal echocardiography in the emergency department | Q91704663 | ||
| A case of refractory ventricular fibrillation successfully treated with low-dose esmolol | Q92247214 | ||
| Key components of a community response to out-of-hospital cardiac arrest | Q92284059 | ||
| Importance of the distinction between recurrent and shock-resistant ventricular fibrillation: Call for a uniform definition of refractory VF | Q92400878 | ||
| Long-term follow-up of adult patients with congenital heart disease and an implantable cardioverter defibrillator | Q92479836 | ||
| Challenge and Impact of Quinidine Access in Sudden Death Syndromes: A National Experience | Q92533555 | ||
| Increased levels of sST2 in patients with mitral annulus disjunction and ventricular arrhythmias | Q92550789 | ||
| Recent understanding of clinical sequencing and gene-based risk stratification in inherited primary arrhythmia syndrome | Q92610493 | ||
| Beneficial Effects of Isoproterenol and Quinidine in the Treatment of Ventricular Fibrillation in Brugada Syndrome | Q35781746 | ||
| A review of Perindopril in the reduction of cardiovascular events | Q36012986 | ||
| Outcomes after ventricular fibrillation out-of-hospital cardiac arrest: expanding the chain of survival | Q36156940 | ||
| Antiarrhythmic action of beta-blockers: potential mechanisms | Q36167672 | ||
| Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators | Q36301539 | ||
| T-wave alternans and the susceptibility to ventricular arrhythmias | Q36368212 | ||
| Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases | Q36416908 | ||
| Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease | Q36597800 | ||
| Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure | Q36704776 | ||
| The role of redox signaling in epigenetics and cardiovascular disease | Q36761147 | ||
| beta-Blockers for the treatment of cardiac arrest from ventricular fibrillation? | Q36926199 | ||
| Emergency coronary angiography in comatose cardiac arrest patients: do real-life experiences support the guidelines? | Q37140992 | ||
| T(p-e)/QT ratio as an index of arrhythmogenesis | Q37268358 | ||
| N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study | Q37304997 | ||
| Cardiac strong inward rectifier potassium channels | Q37585689 | ||
| Molecular biology of K(ATP) channels and implications for health and disease | Q37605024 | ||
| Reliability of the Cerebral Performance Category to classify neurological status among survivors of ventricular fibrillation arrest: a cohort study | Q37889410 | ||
| Beat-to-beat variability of repolarization as a new biomarker for proarrhythmia in vivo. | Q38011515 | ||
| HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. | Q38134931 | ||
| QT Variability Index | Q38161597 | ||
| Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. | Q38409971 | ||
| Molecular basis of funny current (If) in normal and failing human heart. | Q38551800 | ||
| Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care | Q38608801 | ||
| Predicting drug-induced QT prolongation and torsades de pointes | Q38667401 | ||
| Sodium-channel blocker challenge in the familial screening of Brugada syndrome: Safety and predictors of positivity. | Q38699395 | ||
| Ventricular fibrillation: triggers, mechanisms and therapies | Q38819031 | ||
| Is VF an Ablatable Rhythm? | Q38912807 | ||
| Use of double sequential external defibrillation for refractory ventricular fibrillation during out-of-hospital cardiac arrest | Q38926874 | ||
| Traditional and novel electrocardiographic conduction and repolarization markers of sudden cardiac death | Q38972230 | ||
| The meaning of the Tp-Te interval and its diagnostic value | Q39860176 | ||
| The prognostic value of the Tpeak-Tend interval in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction | Q39895058 | ||
| Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry. | Q40274221 | ||
| Proarrhythmic Effects of Intravenous Vasopressors | Q40441752 | ||
| Pharmacokinetic and pharmacodynamic profiles of d-sotalol and d,l-sotalol. | Q40620240 | ||
| Initiating reentry: the role of nonuniform anisotropy in small circuits | Q40754395 | ||
| Sudden cardiac death: epidemiology, transient risk, and intervention assessment | Q40779541 | ||
| Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials | Q40845893 | ||
| A quality improvement initiative to optimize use of a mechanical chest compression device within a high-performance CPR approach to out-of-hospital cardiac arrest resuscitation. | Q41013139 | ||
| Reversal of potassium channel deficiency in cells from failing hearts by adenoviral gene transfer: a prototype for gene therapy for disorders of cardiac excitability and contractility | Q41161525 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Ventricular Fibrillation | Q848662 |
| P304 | page(s) | 1640 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Handling of Ventricular Fibrillation in the Emergency Setting | |
| P478 | volume | 10 |
Search more.